CH
Chugai Pharmaceutical Co., Ltd.
CHGCY · OTC
$20.75 +1.17% (+$0.24)
1M -8.52%
Market Cap ¥11.3T
P/E Ratio 22.70x
Div. Yield 3.73%
ROE 25.19%
Bulios Fair Price
$17.39
16.2% downside
Current Price
$20.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHGCY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
43 /100
Fair EV/EBITDA 15.02x
P/S 7.96x
P/B 5.59x
Growth
59 /100
Stable Rev. growth 1.54%
FCF growth 23.84%
Book val. growth 12.48%
Profitability
100 /100
Strong Net margin 35.08%
Op. margin 48.30%
FCF margin 29.42%
Quality
92 /100
Excellent ROE 25.19%
ROA 20.38%
Asset turnover 0.58x
Debt
100 /100
Low Current ratio 4.35x
Int. coverage 690.10x
Net debt/EBITDA -0.51x
Stability
90 /100
Stable Rev. volatility 12.55%
EPS volatility 18.10%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHGCY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Osamu Okuda
Employees
7,872
Headquarters
Tokyo
Upcoming events
23 OCT
Earnings
Upcoming earnings report
29 DEC
Ex-Dividend
Ex-dividend date
29 MAR
Dividend Payment
Payment date